Novocure Ltd expected to post a loss of 52 cents a share - Earnings Preview

NovoCure

20/02/2024 13:56

* Novocure Ltd  NVCR.OQ   NVCR.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 22 for
the period ending December 31 2023
    * The Saint Helier Jersey-based   company is expected to
report a
2.1% increase in revenue to $131.187 million from $128.43
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data. (Revenue is on Total Revenue.)
    * ​LSEG's mean analyst estimate for Novocure Ltd is for a
loss
of 52 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Novocure
Ltd is
$21.00​, above​ its last closing price of $16.14. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.53       -0.52      -0.46     Beat    12.4
 Jun. 30 2023  -0.49       -0.50      -0.54     Missed  -7.9
 Mar. 31 2023  -0.31       -0.32      -0.50     Missed  -54.5​
 Dec. 31 2022  -0.31       -0.30      -0.36     Missed  -18
 ​​Sep.        -0.26       -0.26      -0.25     Beat    4.4
 30 2022                                                
 Jun. 30 2022  -0.16       -0.14      -0.23     Missed  -58.6​
 Mar. 31 2022  -0.18       -0.18      -0.04     Beat    77.8
 Dec. 31 2021  -0.09       -0.10      -0.25     Missed  -146.5
 This summary was machine generated February 20 at 13:56 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)